More News
Want to Read Locked Articles?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
EC Approves SIFI’s Akantior Drops for Acanthamoeba Keratitis
Author: Jennie Crabbe
Italy’s SIFI announced Aug. 26 that the European Commission had approved Akantior (polihexanide 0.08%) drops for the treatment of Acanthamoeba keratitis (AK), a parasitic infection of the eye, in patients 12 and older. Akantior is the first approved therapy for AK. It has been granted orphan drug designation in both the EU and US. AK is a rare, acute, severe corneal infection caused by Acanthamoeba, a free-living amoeba. AK can lead to poor vision, potential blindness, or even eye loss and of...
